Cambridge Advisors’s Bausch Health BHC Stock Holding History

Cambridge Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,725	Closed	-$240K	–	138
2019 Q1	$240K	Buy	+9,725	New	+$232K	0.08%	124
2018 Q4	–	Sell	-9,825	Closed	-$252K	–	135
2018 Q3	$252K	Sell	9,825 -800	-8%	-$18.3K	0.09%	124
2018 Q2	$247K	Sell	10,625 -250	-2%	-$5.17K	0.09%	124
2018 Q1	$173K	Sell	10,875 -1,400	-11%	-$26.1K	0.06%	142
2017 Q4	$255K	Sell	12,275 -350	-3%	-$5.55K	0.09%	123
2017 Q3	$181K	Sell	12,625 -25	-0.2%	-$378	0.07%	135
2017 Q2	$219K	Hold	12,650	–	–	0.09%	125
2017 Q1	$140K	Buy	12,650 +75	+0.6%	+$1.03K	0.06%	128
2016 Q4	$183K	Buy	+12,575	New	+$231K	0.08%	126

Other funds holding BHC

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Cambridge Advisors's BHC Position: Q2 2019 in Review

Cambridge Advisors sold out of Bausch Health (BHC) in Q2 2019, closing a stake of 9,725 shares — an estimated $240K sold.

Cambridge Advisors first reported a position in BHC in Q4 2016 and held it in 9 quarters. The position peaked at $255K in Q4 2017. 332 funds tracked by Wall St. Rank hold BHC as of Q2 2019.

Cambridge Advisors reported no remaining Bausch Health position as of Q2 2019 after selling out during the quarter.
Cambridge Advisors sold 9,725 Bausch Health shares in Q2 2019, an estimated $240K.
Cambridge Advisors first reported a position in Bausch Health in Q4 2016 and held it in 9 quarters.
Cambridge Advisors's Bausch Health position peaked at $255K in Q4 2017.
332 funds tracked by Wall St. Rank held Bausch Health as of Q2 2019.

Based on Cambridge Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.